MHRA reports latest Yellow Card reporting data for coronavirus vaccines

Based on analysis of data up to 21 April, the overall case incidence of major thromboembolic events with concurrent thrombocytopenia reported in recipients of the Covid-19 Vaccine AstraZeneca was 9.3 per million doses (209 cases, including 84 of cerebral venous sinus thrombosis).

Source:

Medicines and Healthcare products Regulatory Agency